Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2005
12/31/2004
12/31/2003
12/31/2002
12/31/2001
Revenue
396
410
367
220
122
15
Revenue Growth (YoY)
21%
12%
67%
80%
713%
--
Cost of Revenue
322
323
282
158
86
10
Gross Profit
74
86
84
61
36
5
Selling, General & Admin
78
82
81
56
33
9
Research & Development
--
--
--
--
--
--
Operating Expenses
83
87
85
59
35
10
Other Non Operating Income (Expenses)
6
0
-3
-1
0
0
Pretax Income
-28
-6
-9
0
0
-3
Income Tax Expense
0
1
2
0
0
0
Net Income
-29
-9
-13
0
15
-21
Net Income Growth
93%
-31%
--
-100%
-171%
-74%
Shares Outstanding (Diluted)
43.77
43.59
38.97
29.62
29.23
20.51
Shares Change (YoY)
0%
12%
32%
1%
43%
16%
EPS (Diluted)
-0.65
-0.22
-0.33
-0.01
0.52
-1.05
EPS Growth
92%
-33%
1,798%
-103%
-150%
-77%
Free Cash Flow
-1
3
-6
-8
-2
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
18.68%
20.97%
22.88%
27.72%
29.5%
33.33%
Operating Margin
-2.27%
0%
-0.27%
0.9%
0%
-26.66%
Profit Margin
-7.32%
-2.19%
-3.54%
0%
12.29%
-140%
Free Cash Flow Margin
-0.25%
0.73%
-1.63%
-3.63%
-1.63%
0%
EBITDA
-6
4
3
4
2
-4
EBITDA Margin
-1.51%
0.97%
0.81%
1.81%
1.63%
-26.66%
D&A For EBITDA
3
4
4
2
2
0
EBIT
-9
0
-1
2
0
-4
EBIT Margin
-2.27%
0%
-0.27%
0.9%
0%
-26.66%
Effective Tax Rate
0%
-16.66%
-22.22%
0%
0%
0%
Follow-Up Questions
What are Canntab Therapeutics Limited's key financial statements?
According to the latest financial statement (Form-10K), Stonepath Group Inc has a total asset of $135, Net loss of $-9
What are the key financial ratios for CTABF?
Stonepath Group Inc's Current ratio is 1.4, has a Net margin is -2.19, sales per share of $9.4.
How is Canntab Therapeutics Limited's revenue broken down by segment or geography?
Stonepath Group Inc largest revenue segment is Retail, at a revenue of 1,816,241,000,000 in the most earnings release.For geography, Chile is the primary market for Stonepath Group Inc, at a revenue of 2,997,276,000,000.
Is Canntab Therapeutics Limited profitable?
no, according to the latest financial statements, Stonepath Group Inc has a net loss of $-9
Does Canntab Therapeutics Limited have any liabilities?
yes, Stonepath Group Inc has liability of 96
How many outstanding shares for Canntab Therapeutics Limited?
Stonepath Group Inc has a total outstanding shares of 43.74